Research GradeWeight Management & Metabolic

CJC-1295 with DAC

5 mg

DAC-modified GHRH analogue with extended half-life.

Overview

CJC-1295 with Drug Affinity Complex (DAC) covalently binds albumin in plasma, extending half-life from minutes to days for sustained GHRH receptor engagement.

Mechanism of Action

Albumin-bound depot releases CJC-1295 gradually, maintaining tonic GHRH receptor activation and elevated baseline GH secretion.

Research Findings

DAC-GRF Pharmacokinetics

J. Endocrinol., 2005

Half-life characterization of DAC variant.

Potential Research Applications

Sustained-release pharmacology
Long-acting GHRH research

Often researched with

CJC-1295

5 mg

GHRH analogue studied for growth-hormone axis research.

Ipamorelin

5 mg

Selective ghrelin receptor agonist studied for GH release.